University of South Alabama, Mobile, Alabama, USA.
Environ Mol Mutagen. 2010 Jun;51(5):451-61. doi: 10.1002/em.20570.
Over the past decade a large volume of research data has accumulated which has established a fundamental role for mitochondria in normal cellular functioning, as well as in various pathologies. Mitochondria play a pivotal role in metabolism and energy production, and are one of the key players involved in programmed cell death. On the other hand, mitochondrial dysfunction is implicated, directly or indirectly in numerous pathological conditions including inherited mitochondrial disorders, diabetes, cardiovascular and neurodegenerative diseases, and a variety of malignancies. The ability to modulate mitochondrial function by altering the diverse protein component of this organelle may be of great value for developing future therapeutic interventions. This review will discuss approaches used to introduce proteins into mitochondria. One group of methods utilizes strategies aimed at expressing proteins from genes in the nucleus. These include overexpression of nuclear-encoded mitochondrial proteins, allotopic expression, which is the re-coding and relocation of mitochondrial genes to the nucleus for expression and subsequent delivery of their gene products to mitochondria, and xenotopic expression, which is the nuclear expression of genes coding electron transport chain components from distant species, for delivery of their products to mammalian mitochondria. Additionally, antigenomic and progenomic strategies which focus on expression of mitochondrially targeted nuclear proteins involved in the maintenance of mtDNA will be discussed. The second group of methods considered will focus on attempts to use purified proteins for mitochondrial delivery. Special consideration has been given to the complexities involved in targeting exogenous proteins to mitochondria.
在过去的十年中,大量的研究数据积累起来,确立了线粒体在正常细胞功能以及各种病理中的基本作用。线粒体在代谢和能量产生中起着关键作用,是参与程序性细胞死亡的关键因素之一。另一方面,线粒体功能障碍直接或间接地涉及许多病理状况,包括遗传性线粒体疾病、糖尿病、心血管和神经退行性疾病以及各种恶性肿瘤。通过改变细胞器的多种蛋白质成分来调节线粒体功能的能力对于开发未来的治疗干预措施可能具有重要价值。本文综述了将蛋白质导入线粒体的方法。一组方法利用旨在从核基因中表达蛋白质的策略。这些策略包括核编码线粒体蛋白的过表达、异位表达,即将线粒体基因重新编码并转移到核中进行表达,然后将其基因产物递送到线粒体;以及异源表达,即从远缘物种的核表达编码电子传递链成分的基因,将其产物递送到哺乳动物的线粒体。此外,还将讨论专注于表达涉及 mtDNA 维持的靶向核线粒体蛋白的反基因组和前基因组策略。下一组方法将集中于尝试使用纯化的蛋白质进行线粒体传递。特别考虑了将外源蛋白靶向线粒体所涉及的复杂性。